Graduate of Lomonosov Moscow State University. His area of scientific interest is the development of “Man-on-a-chip” technology to study the effects of xenobiotics on human cells. He has developed the “Homunculus” biotechnological platform, which ensures long-term integrity of cells inside the body and reproduces the chain of human processes. Pilot production was organized, and currently the Homunculus platform has been patented and is being implemented in preclinical drug research, personalized medicine and basic research.